← Back to Clinical Trials
Recruiting NCT06471413

NCT06471413 Evaluation of the Effect of the BOAT® Structured Prevention Program on Violence in Middle Schools

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06471413
Status Recruiting
Phase
Sponsor University Hospital, Montpellier
Condition Students
Study Type OBSERVATIONAL
Enrollment 5,400 participants
Start Date 2025-04-02
Primary Completion 2027-06-01

Eligibility & Interventions

Sex All sexes
Min Age 13 Years
Max Age 17 Years
Study Type OBSERVATIONAL
Interventions
The Prevention Toolbox : BOAT®

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 5,400 participants in total. It began in 2025-04-02 with a primary completion date of 2027-06-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Violence has major consequences for the health and development of children and teenagers, even though it is commonplace, particularly in secondary schools. The team at the Centre Ressources pour les Intervenants auprès d'Auteurs de Violences Sexuelles Languedoc-Roussillon (CRIAVS-LR, CHU Montpellier) has created a BOite A ouTils to prevent sexual and gender-based violence: the BOAT, for professionals working with children and teenagers aged between 5 and 18. Structured around 5 themes and 4 age groups, the BOAT is very easy to use. The 134 intervention sheets have been validated and designed to target a risk factor (to be reduced) or a protective factor (to be developed) so that children do not become perpetrators or victims of violence.

Eligibility Criteria

Inclusion Criteria: * Middle school students: students enrolled in a middle school included in the study, enrolled in the fourth or ninth grade and randomly selected to participate in the research. The age of a fourth or ninth grader is between 13 and 17. * Educational team: professionals and teachers working in a middle school participating in the research (included in the study). Exclusion Criteria: * Schoolchildren: opposition to participation in the search by the child's parents (or one of the 2 parents with parental authority) and/or opposition by the child. * Educational team: opposition to participation in the search. * Person unable to speak French * Person unable to understand the nature, purpose and methodology of the study

Contact & Investigator

Central Contact

Mathieu LACAMBRE, PH

✉ m-lacambre@chu-montpellier.fr

📞 0467338577

Frequently Asked Questions

Who can join the NCT06471413 clinical trial?

This trial is open to participants of all sexes, aged 13 Years or older, up to 17 Years, studying Students. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06471413 currently recruiting?

Yes, NCT06471413 is actively recruiting participants. Contact the research team at m-lacambre@chu-montpellier.fr for enrollment information.

Where is the NCT06471413 trial being conducted?

This trial is being conducted at Montpellier, France.

Who is sponsoring the NCT06471413 clinical trial?

NCT06471413 is sponsored by University Hospital, Montpellier. The trial plans to enroll 5,400 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology